Back

Early detection of cardio-toxicity: the role of biomarkers.

28 May 2019 (08:48 - 09:06)
Organised by:
Congress Presentation Part of: Clinical approach to cardio-oncological patient Cardiotoxicity of Drugs and Other Therapies HFA Premium Access Heart Failure 2019

About the speaker

Photo
Doctor Daniela Cardinale

European Institute of Oncology (IEO), Milan (Italy)

4 More presentations in this session

Presentation thumbnail
Early detection of cardio-toxicity: the role of imaging.
Doctor T. Lopez Fernandez (Madrid, ES)
Slides Video
Presentation thumbnail
Prevention of cardiotoxicity.
Doctor K. Keramida (Athens, GR)
Slides Video
Presentation thumbnail
Medical Interventions.
Professor R. De Boer (Rotterdam, NL)
Presentation thumbnail
How to start a cardio-oncology service.
Doctor A. Lyon (London, GB)
Slides Video

Access the full session

Session thumbnail
Clinical approach to cardio-oncological patient

The Event

Event poster

Heart Failure 2019

28 May 2019 08:48 CET
You may be interested in
thumbnail
Webinar
ACVC Biomarker Talk Series - Cardiac biomarkers in the field of cardio-oncology
19 October 2022
thumbnail
Congress Presentation
Identifying a cardioprotective agent using human quadricellular cardiovascular organoids for modelling chemotherapy-induced cardiomyopathy.
22 May 2023
thumbnail
Congress Presentation
Role of myocardial work in identifying anthracycline-induced cardiotoxicity and its correlation with metabolic fingerprinting in patients with breast cancer
21 June 2025
thumbnail
Congress Session
Role of multi-modality imaging for cardiomyopathy in children and young people
10 May 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources